IMVT
Price
$15.34
Change
-$0.10 (-0.65%)
Updated
Jun 4 closing price
Capitalization
2.62B
62 days until earnings call
LSTA
Price
$2.66
Change
+$0.06 (+2.31%)
Updated
Jun 4 closing price
Capitalization
22.87M
74 days until earnings call
Interact to see
Advertisement

IMVT vs LSTA

Header iconIMVT vs LSTA Comparison
Open Charts IMVT vs LSTABanner chart's image
Immunovant
Price$15.34
Change-$0.10 (-0.65%)
Volume$737.48K
Capitalization2.62B
Lisata Therapeutics
Price$2.66
Change+$0.06 (+2.31%)
Volume$8.61K
Capitalization22.87M
IMVT vs LSTA Comparison Chart
Loading...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMVT vs. LSTA commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Hold and LSTA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (IMVT: $15.34 vs. LSTA: $2.66)
Brand notoriety: IMVT and LSTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 48% vs. LSTA: 61%
Market capitalization -- IMVT: $2.62B vs. LSTA: $22.87M
IMVT [@Biotechnology] is valued at $2.62B. LSTA’s [@Biotechnology] market capitalization is $22.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green whileLSTA’s FA Score has 1 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • LSTA’s FA Score: 1 green, 4 red.
According to our system of comparison, LSTA is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 3 TA indicator(s) are bullish while LSTA’s TA Score has 5 bullish TA indicator(s).

  • IMVT’s TA Score: 3 bullish, 3 bearish.
  • LSTA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LSTA is a better buy in the short-term than IMVT.

Price Growth

IMVT (@Biotechnology) experienced а +7.35% price change this week, while LSTA (@Biotechnology) price change was -0.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.56%. For the same industry, the average monthly price growth was +5.22%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

IMVT is expected to report earnings on Aug 06, 2025.

LSTA is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+6.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($2.62B) has a higher market cap than LSTA($22.9M). LSTA YTD gains are higher at: -10.738 vs. IMVT (-38.070). LSTA has higher annual earnings (EBITDA): -22.24M vs. IMVT (-404.87M). IMVT has more cash in the bank: 375M vs. LSTA (31.2M). IMVT has less debt than LSTA: IMVT (23K) vs LSTA (137K). LSTA has higher revenues than IMVT: LSTA (1M) vs IMVT (0).
IMVTLSTAIMVT / LSTA
Capitalization2.62B22.9M11,450%
EBITDA-404.87M-22.24M1,821%
Gain YTD-38.070-10.738355%
P/E RatioN/AN/A-
Revenue01M-
Total Cash375M31.2M1,202%
Total Debt23K137K17%
FUNDAMENTALS RATINGS
IMVT vs LSTA: Fundamental Ratings
IMVT
LSTA
OUTLOOK RATING
1..100
877
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9494
PRICE GROWTH RATING
1..100
8651
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LSTA's Valuation (23) in the null industry is in the same range as IMVT (43). This means that LSTA’s stock grew similarly to IMVT’s over the last 12 months.

LSTA's Profit vs Risk Rating (100) in the null industry is in the same range as IMVT (100). This means that LSTA’s stock grew similarly to IMVT’s over the last 12 months.

LSTA's SMR Rating (94) in the null industry is in the same range as IMVT (94). This means that LSTA’s stock grew similarly to IMVT’s over the last 12 months.

LSTA's Price Growth Rating (51) in the null industry is somewhat better than the same rating for IMVT (86). This means that LSTA’s stock grew somewhat faster than IMVT’s over the last 12 months.

LSTA's P/E Growth Rating (100) in the null industry is in the same range as IMVT (100). This means that LSTA’s stock grew similarly to IMVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMVTLSTA
RSI
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAFBX36.380.17
+0.47%
American Funds AMCAP R2
VGISX34.85N/A
N/A
Virtus Duff & Phelps Glb Rl Estt Secs I
BRXTX15.14N/A
N/A
MFS Blended Research Intl Eq R3
SPISX64.21N/A
N/A
Invesco S&P 500 Index R6
ETIEX13.33N/A
N/A
Eventide Exponential Technologies I

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
-0.65%
ROIV - IMVT
60%
Loosely correlated
-0.31%
OCUL - IMVT
48%
Loosely correlated
+0.60%
BRNS - IMVT
48%
Loosely correlated
-6.48%
KYMR - IMVT
47%
Loosely correlated
+1.56%
COGT - IMVT
46%
Loosely correlated
-2.59%
More

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and RAIN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and RAIN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
+2.18%
RAIN - LSTA
29%
Poorly correlated
+22.50%
ASND - LSTA
26%
Poorly correlated
-0.41%
GMAB - LSTA
26%
Poorly correlated
+2.01%
IMVT - LSTA
25%
Poorly correlated
-0.65%
MRUS - LSTA
25%
Poorly correlated
-7.75%
More